![Robert Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Clark
Directeur/Bestuurslid bij
INCANNEX HEALTHCARE INC.
Vermogen: 8 375 $ op 31-05-2026
Profiel
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2023 and Novo Nordisk, Inc., as Vice President-US Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Incannex Healthcare Pty Ltd., as Director from 2022 to 2023 and Pfizer Inc., as VP-Worldwide Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-11-2025 | 2.500 ( 0,02% ) | 8 375 $ | 31-05-2026 |
Actieve functies van Robert Clark
| Bedrijven | Functie | Begin |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Bestuurslid | 01-11-2023 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Algemeen Adviseur | 01-01-2012 |
Eerdere bekende functies van Robert Clark
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Robert Clark
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Incannex Healthcare, Inc.
 Incannex Healthcare, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cannabinoid and psychedelic compound medicines | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
